Paper41909658
Therapeutic hepatitis B vaccine employing DNA prime - MVA boost scheme requires additional priming with recombinant HBsAg to elicit an adequate antibody response.
Kerth HA and 15 others. Front Immunol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Therapeutic hepatitis B vaccine employing DNA prime - MVA boost scheme requires additional priming with recombinant HBsAg to elicit an adequate antibody response. Papers, record 41909658. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41909658
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Therapeutic hepatitis B vaccine employing DNA prime - MVA boost scheme requires additional priming with recombinant HBsAg to elicit an adequate antibody response.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Vaccines, DNA | Major topic |
| Hepatitis B Surface Antigens | Major topic |
| Hepatitis B Vaccines | Major topic |
| Hepatitis B virus | Major topic |
| Hepatitis B, Chronic | Major topic |
| Animals | |
| Mice | |
| Immunization, Secondary | |
| Female | |
| CD8-Positive T-Lymphocytes | |
| Vaccinia virus | |
| Hepatitis B Antibodies | |
| Humans | |
| Antibody Formation | |
| Vaccination |
Source PubMed
References52
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15613305 | Neutralizing antibodies elicited by immunization of monkeys with DNA plasmids and recombinant adenoviral vectors expressing human immunodeficiency virus type 1 proteins. | J Virol | 2005 | https://conductscience.org/library/papers/15613305 | PubMed |
| 2 | 34113610 | A Guide to Nucleic Acid Vaccines in the Prevention and Treatment of Infectious Diseases and Cancers: From Basic Principles to Current Applications. | Front Cell Dev Biol | 2021 | https://conductscience.org/library/papers/34113610 | PubMed |
| 3 | 11130078 | A Toll-like receptor recognizes bacterial DNA. | Nature | 2000 | https://conductscience.org/library/papers/11130078 | PubMed |
| 4 | 39937851 | Liver-specific transgenic expression of human NTCP in rhesus macaques confers HBV susceptibility on primary hepatocytes. | Proc Natl Acad Sci U S A | 2025 | https://conductscience.org/library/papers/39937851 | PubMed |
| 5 | 19500964 | Heterologous prime-boost vaccination. | Curr Opin Immunol | 2009 | https://conductscience.org/library/papers/19500964 | PubMed |
| 6 | 12200054 | Alternative processing of endogenous or exogenous antigens extends the immunogenic, H-2 class I-restricted peptide repertoire. | Mol Immunol | 2002 | https://conductscience.org/library/papers/12200054 | PubMed |
| 7 | 31346211 | Synergy of therapeutic heterologous prime-boost hepatitis B vaccination with CpG-application to improve immune control of persistent HBV infection. | Sci Rep | 2019 | https://conductscience.org/library/papers/31346211 | PubMed |
| 8 | 31548710 | Restoring, releasing or replacing adaptive immunity in chronic hepatitis B. | Nat Rev Gastroenterol Hepatol | 2019 | https://conductscience.org/library/papers/31548710 | PubMed |
| 9 | 26776470 | Protein-prime/modified vaccinia virus Ankara vector-boost vaccination overcomes tolerance in high-antigenemic HBV-transgenic mice. | Vaccine | 2016 | https://conductscience.org/library/papers/26776470 | PubMed |
| 10 | 15100299 | Induction in humans of CD8+ and CD4+ T cell and antibody responses by sequential immunization with malaria DNA and recombinant protein. | J Immunol | 2004 | https://conductscience.org/library/papers/15100299 | PubMed |
| 11 | 21602908 | High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice. | PLoS One | 2011 | https://conductscience.org/library/papers/21602908 | PubMed |
| 12 | 18343847 | Occurrence, function and evolutionary origins of '2A-like' sequences in virus genomes. | J Gen Virol | 2008 | https://conductscience.org/library/papers/18343847 | PubMed |
| 13 | 34284057 | Intramolecular recombination enables the formation of hepatitis B virus (HBV) cccDNA in mice after HBV genome transfer using recombinant AAV vectors. | Antiviral Res | 2021 | https://conductscience.org/library/papers/34284057 | PubMed |
| 14 | 12938219 | Different immunogenicity of H-2 Kb-restricted epitopes in natural variants of the hepatitis B surface antigen. | Eur J Immunol | 2003 | https://conductscience.org/library/papers/12938219 | PubMed |
| 15 | 38012018 | Delineation of DNA and mRNA COVID-19 vaccine-induced immune responses in preclinical animal models. | Hum Vaccin Immunother | 2023 | https://conductscience.org/library/papers/38012018 | PubMed |
| 16 | 28453967 | Therapeutic vaccination for chronic hepatitis B. | Curr Opin Virol | 2017 | https://conductscience.org/library/papers/28453967 | PubMed |
| 17 | 30326600 | The Global Hepatitis B Virus Genotype Distribution Approximated from Available Genotyping Data. | Genes (Basel) | 2018 | https://conductscience.org/library/papers/30326600 | PubMed |
| 18 | 34452368 | Rapid and Robust Continuous Purification of High-Titer Hepatitis B Virus for In Vitro and In Vivo Applications. | Viruses | 2021 | https://conductscience.org/library/papers/34452368 | PubMed |
| 19 | 10846081 | Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target Gag antigen to the secretory pathway. | J Virol | 2000 | https://conductscience.org/library/papers/10846081 | PubMed |
| 20 | 9989985 | T cell affinity maturation by selective expansion during infection. | J Exp Med | 1999 | https://conductscience.org/library/papers/9989985 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41909658
GET https://conductscience.org/api/papers/v1/41909658/references?page=2